BKL supports ambitious tech firm Lumeon in securing $28m funding for US growth
Global healthtech business Lumeon has raised funds to expand its commercial operations, with advice from BKL.
Lumeon is the leader in care pathway management. It has secured funding from Life Sciences Partners, one of the largest healthcare investment firms in Europe, to grow its US team and customer base.
The company is at the cutting edge of healthcare, helping providers to maximise their efficiency. Lumeon builds on existing electronic health records with advanced patient engagement techniques, ensuring best practice and reducing costs.
Dominic Anthony, Business Services Partner at BKL, said: “We are delighted to be part of Lumeon’s journey as the company grows, helping it to meet the challenges and opportunities that lie ahead.”
BKL is a Top 50 firm of chartered accountants and advisers with London and Cambridge offices. Their specialties include supporting technology and digital companies with structuring, growth and fundraising.
Dominic adds: “Lumeon is part of a fascinating, fast-changing world, and we at BKL are very focused on helping technology and digital businesses to achieve their potential, particularly in meeting tax and regulatory challenges.”
John Freeman, Chief Financial Officer at Lumeon, said: “Having worked with BKL for a number of years, we were confident in their ability to guide us through a rigorous due diligence process and assist with our plans for the future. The BKL team worked with us to tight deadlines and were a valuable resource on the financial and regulatory issues of a complex transaction.”